Remote ischaemic conditioning: cardiac protection from afar

por Sivaraman, V., Pickard, J. M. J., Hausenloy, D. J.
Publicado 2015

Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular disease

por Hall, A R, Burke, N, Dongworth, R K, Hausenloy, D J
Publicado 2014

Role of the MPTP in conditioning the heart – translatability and mechanism

por Ong, S‐B, Dongworth, R K, Cabrera‐Fuentes, H A, Hausenloy, D J
Publicado 2015

Correction: Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction

por Hall, A. R., Burke, N., Dongworth, R. K., Kalkhoran, S. B., Dyson, A., Vicencio, J. M., Dorn, G. W., Yellon, D. M., Hausenloy, D. J.
Publicado 2021

Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction

por Hall, A R, Burke, N, Dongworth, R K, Kalkhoran, S B, Dyson, A, Vicencio, J M, Dorn II, G W, Yellon, D M, Hausenloy, D J
Publicado 2016

DJ-1 protects against cell death following acute cardiac ischemia–reperfusion injury

por Dongworth, R K, Mukherjee, U A, Hall, A R, Astin, R, Ong, S-B, Yao, Z, Dyson, A, Szabadkai, G, Davidson, S M, Yellon, D M, Hausenloy, D J
Publicado 2014

Remote ischaemic conditioning: defining critical criteria for success—report from the 11th Hatter Cardiovascular Workshop

por Bell, R. M., Basalay, M., Bøtker, H. E., Beikoghli Kalkhoran, S., Carr, R. D., Cunningham, J., Davidson, S. M., England, T. J., Giesz, S., Ghosh, A. K., Golforoush, P., Gourine, A. V., Hausenloy, D. J., Heusch, G., Ibanez, B., Kleinbongard, P., Lecour, S., Lukhna, K., Ntsekhe, M., Ovize, M., Salama, A. D., Vilahur, G., Walker, J. M., Yellon, D. M.
Publicado 2022